EXHIBIT 10.25 STANDARD FORM COMMERCIAL LEASE Steven D. Rosenberg as Trustee of the Fifth Street 1. PARTIES Realty Trust of 300 Bent Street, Cambridge, MA 02141 (fill in) LESSOR, which expression shall include his heirs, successors, and assigns where...Biogen Idec Inc • March 31st, 2005 • Biological products, (no disgnostic substances)
EXECUTION COPY THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Brainstorm Cell Therapeutics Inc • August 10th, 2005 • Biological products, (no disgnostic substances) • New York
EXHIBIT 1.1 4,761,905 SHARES OF COMMON STOCK AND 4,761,905 WARRANTS OF CEL-SCI CORPORATION UNDERWRITING AGREEMENTCel Sci Corp • December 19th, 2013 • Biological products, (no disgnostic substances) • New York
EXHIBIT 4(q) NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION...Cel Sci Corp • May 2nd, 2017 • Biological products, (no disgnostic substances)
EXHIBIT 10.24c SECOND AMENDMENT TO SUBLEASE THIS SECOND AMENDMENT TO SUBLEASE ("Second Amendment") is made as of June 1, 2004 by and between Sorrento Montana, LP., a California Limited Partnership ("Landlord") and Integra NeuroSciences CA Corporation,...Integra Lifesciences Holdings Corp • March 16th, 2005 • Biological products, (no disgnostic substances)
EMPLOYMENT AGREEMENT DATE: December 17, 2004 PARTIES: Techne Corporation, a Minnesota corporation 614 McKinley Place N.E. Minneapolis, Minnesota 55413 Gregory J. Melsen AGREEMENTS: ARTICLE 1. TERM OF EMPLOYMENT: DUTIES AND SUPERVISION 1.1) Parties....Employment Agreement • December 20th, 2004 • Techne Corp /Mn/ • Biological products, (no disgnostic substances) • Minnesota
RECITALSRegistration Rights Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 99.2 Published CUSIP Number: [________________] CREDIT AGREEMENT Dated as of June 29, 2007Credit Agreement • July 2nd, 2007 • Biogen Idec Inc. • Biological products, (no disgnostic substances) • New York
Exhibit 10.3 SIXTH AMENDMENT TO EMPLOYMENT AGREEMENT This AMENDMENT TO EMPLOYMENT AGREEMENT (the " Sixth Amendment") made as of September 2, 2003 between ARIAD Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and David Berstein, Esq....Employment Agreement • November 4th, 2003 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
MADE AS OF JUNE 1, 1998, BETWEENStock Purchase Agreement • February 5th, 1999 • Phoenix International Industries Inc /Fl/ • Biological products, (no disgnostic substances) • Georgia
as Issuer andIndenture • May 25th, 2006 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
WITNESSETH:Lease Agreement • August 9th, 2007 • Third Wave Technologies Inc /Wi • Biological products, (no disgnostic substances) • Wisconsin
Exhibit 10.12 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the first day of November, 2004, by and between Daniel J. Kerkman ("Employee"), and APPLIED NEUROSOLUTIONS, INC. ("APNS"), a Delaware corporation...Employment Agreement • March 25th, 2005 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Illinois
Exhibit 10.4 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Brainstorm Cell Therapeutics Inc • April 4th, 2006 • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.55 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made as of October 5, 2001 (the "Effective Date") by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Brian A. Lajoie (the...Consulting Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
RECITALSAgreement • January 30th, 2003 • Vitro Diagnostics Inc • Biological products, (no disgnostic substances)
EXHIBIT 4.2Escrow Agreement • March 4th, 2005 • Xechem International Inc • Biological products, (no disgnostic substances) • New York
RECITALSPurchase Agreement • February 13th, 2004 • Hemoxymed Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10(k)Cel Sci Corp • July 2nd, 2009 • Biological products, (no disgnostic substances)
COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.Eloxx Pharmaceuticals, Inc. • November 13th, 2023 • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 19, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 380,590 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
RECITALSVoting Agreement • February 28th, 2003 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Pledgor has, on this date, executed and delivered to Pledgees or their assigns a promissory note dated the date hereof in the principal amount of Two Hundred Seventy Nine Million Four Hundred Seventeen Thousand and Nine Hundred Eighty- two Dollars...Pledge Agreement • January 18th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
ANDManagement Agreement • September 8th, 2003 • Zein Youssef El • Biological products, (no disgnostic substances) • Isle of Man
Exhibit 10.20 BIOSANTE PHARMACEUTICALS, INC. SUBSCRIPTION AGREEMENT BioSante Pharmaceuticals, Inc. 175 Olde Half Day Road, Suite 247 Lincolnshire, IL 60069 Attn: Mr. Stephen M. Simes Ladies and Gentlemen: 1. SUBSCRIPTION. The undersigned is hereby...Subscription Agreement • June 29th, 2001 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Illinois
EXHIBIT 10.1 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASSIGNMENT AND...Stock Purchase Agreement • July 27th, 2005 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
EXECUTION COPYLoan and Security Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.13 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective as of this 1st day of January, 2003, by and between STEVEN A. GOULD, M.D. ("Employee") and NORTHFIELD LABORATORIES INC., a Delaware corporation (the "Company"). W I T N E S S E T H : -...Employment Agreement • June 27th, 2003 • Northfield Laboratories Inc /De/ • Biological products, (no disgnostic substances) • Illinois
EXHIBIT 10.2 DISTRIBUTION AGREEMENTDistribution Agreement • May 14th, 2003 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances)
Exhibit 10.13 BRAINSTORM CELL THERAPEUTICS INC. OPTION AGREEMENT Made effective as of the 31st day of December, 2004 BETWEEN: Brainstorm Cell Therapeutics Inc. A company incorporated in Washington (hereinafter the "Company")Option Agreement • April 1st, 2005 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
BY AND AMONG AMGEN INC.,Agreement and Plan of Merger • December 17th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 19th, 2023 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of _______ between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
BY AND AMONGAgreement and Plan of Merger • May 2nd, 2005 • Corixa Corp • Biological products, (no disgnostic substances) • Delaware
FIRST SUPPLEMENTAL INDENTURESupplemental Indenture • January 15th, 1998 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
RECITALS:Stock Option Agreement • March 9th, 2005 • Xechem International Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10(sss) SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of April 30, 2017, between CEL-SCI Corporation, a Colorado corporation (the "Company"), and each purchaser identified on the signature...Securities Purchase Agreement • May 2nd, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
